Early research (Phase 1)Ended earlyNCT03761069What this trial is testingStudy of PTC299 (Emvododstat) in Relapsed/Refractory Acute LeukemiasWho this might be right forLeukemia, Myeloid, AcuteAML PTC Therapeutics 33
Testing effectiveness (Phase 2)Looking for participantsNCT07502768What this trial is testingTislelizumab Plus Zeprumetostat for Relapsed or Refractory NK/T-Cell LymphomaWho this might be right forExtranodal NK/T-cell LymphomaNK/T-cell LymphomaRelapsed or Refractory NK/T-Cell Lymphoma Rong Tao 107
Testing effectiveness (Phase 2)Study completedNCT01807546What this trial is testingOral Rigosertib for Squamous Cell CarcinomaWho this might be right forHead and Neck Squamous Cell CarcinomaAnal Squamous Cell CarcinomaLung Squamous Cell Carcinoma+4 more Traws Pharma, Inc. 64
Early research (Phase 1)Study completedNCT00741403What this trial is testingA Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced MalignanciesWho this might be right forAdvanced CancerMetastatic CancerLymphoma+2 more Cornerstone Pharmaceuticals 39
Large-scale testing (Phase 3)Active Not RecruitingNCT04181827What this trial is testingA Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Janssen Research & Development, LLC 419
Testing effectiveness (Phase 2)Study completedNCT01001442What this trial is testingSafety and Dose Determining Multi-dose Study of BT062 in Patients With Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Biotest Pharmaceuticals Corporation 35
Testing effectiveness (Phase 2)Study completedNCT01202877What this trial is testingPKC412 and 5-AzacytidineWho this might be right forLeukemia M.D. Anderson Cancer Center 54
Testing effectiveness (Phase 2)Study completedNCT00565981What this trial is testingA Pilot Trial With Subcutaneous Alemtuzumab and Oral Fludarabinephosphate for the Determination of Safety, Efficacy and Molecular Profiling for the Prediction of ResponseWho this might be right forB-cell Chronic Lymphocytic Leukemia Arbeitsgemeinschaft medikamentoese Tumortherapie 10
Testing effectiveness (Phase 2)Looking for participantsNCT06503107What this trial is testingNanobody-based Biepitope CAR-T Cells Targeting BCMA in the Treatment of R/RMMWho this might be right forMultiple Myeloma Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 60
Large-scale testing (Phase 3)Study completedNCT00437307What this trial is testingHycamtin Plus Carboplatin Versus Established Regimens for the Treatment of Ovarian Cancer RelapseWho this might be right forOvarian Cancer North Eastern German Society of Gynaecological Oncology 550
Early research (Phase 1)Study completedNCT02316964What this trial is testingDecitabine, Donor Natural Killer Cells, and Aldesleukin in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+5 more Sumithira Vasu 8
Testing effectiveness (Phase 2)UnknownNCT05918198What this trial is testingClinical Study of Venetoclax Combined With CAG in the Treatment of Refractory/Relapsed Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Peking University People's Hospital 52
Early research (Phase 1)Looking for participantsNCT06375044What this trial is testingStudy of SIM0500 Alone in Participants With Relapsed or Refractory Multiple MyelomaWho this might be right forRelapsed or Refractory Multiple Myeloma Jiangsu Simcere Pharmaceutical Co., Ltd. 130
Early research (Phase 1)Looking for participantsNCT06792734What this trial is testingPhase 1 Trial of BTM-3566 in Relapsed/Refractory Mature B Cell LymphomasWho this might be right forLymphoma, B-Cell Bantam Pharmaceuticals 24
Early research (Phase 1)Study completedNCT00039481What this trial is testingOblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid TumorsWho this might be right forCardiac ToxicityUnspecified Childhood Solid Tumor, Protocol Specific National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT05253807What this trial is testingStudy to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR AlterationWho this might be right forNon-Small Cell Lung Cancer (NSCLC) Incyte Corporation 8
Early research (Phase 1)Ended earlyNCT04855136What this trial is testingSafety and Efficacy of bb2121 (Ide-cel) Combinations in Multiple MyelomaWho this might be right forMultiple Myeloma Celgene 21
Very early researchUnknownNCT06277011What this trial is testingSafety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical ResearchWho this might be right forAcute Lymphoblastic LeukemiaNon-hodgkin Lymphoma Anhui Provincial Hospital 18
Early research (Phase 1)Study completedNCT01059071What this trial is testingSafety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With EtoposideWho this might be right forNeuroblastoma Giselle Sholler 21
Early research (Phase 1)Active Not RecruitingNCT02159495What this trial is testingGenetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell NeoplasmWho this might be right forAdult Acute Myeloid Leukemia in RemissionAcute Biphenotypic LeukemiaEarly Relapse of Acute Myeloid Leukemia+10 more City of Hope Medical Center 31